Heads

Sharing highlights from our recent town hall, where we came together as a collective force, uniting the talented teams of Veeda, BIONEEDS INDIA PRIVATE LIMITED, and Heads. We extend a warm welcome to our new colleagues from Heads, embracing them into Veeda family with excitement. During the town hall Dr. Mahesh Bhalgat and Mr. Binoy Gardi expressed their sincere appreciation for the expertise and dedication that each member brings to our collective mission. Together, we embark on a journey of collaboration and growth. We are excited to have Mr George Kouvatseas, Mr. Leonidas Kostagiolas, and Mr. Ioannis Orfanidis from the Heads leadership team join us. As we integrate our strengths and expertise, we recognize the importance of humility and teamwork in driving our shared goals forward. Together, we are committed to achieving excellence in serving our clients and advancing global scientific research. Thanks to everyone who joined! To know more, visit www.veedacr.com or write to us at info@veedacr.com Partners in creating a healthier tomorrow. #Veeda #VeedaGroup #Townhall #Heads #Bioneeds #TownhallMeeting #TeamMeeting

We are excited to share comments from Mr. George Kouvatseas on Veeda's recent acquisition of Heads. Visit the link to know more about this acquisition https://bit.ly/4aeyQ0k or write to us at info@veedacr.com Partners in creating a healthier tomorrow. #Veeda #VeedaGroup #HealthDataSpecialists #Heads #Aquisition #CRO #ClinicalResearchOrganization

Check out the comments from our Group CEO, Dr. Mahesh Bhalgat about Veeda's recent acquisition of Health Data Specialists (Heads), a Europe-based CRO recognized as a global leader in Oncology Trials.   Visit the link to know more about this acquisition https://bit.ly/4aeyQ0k or write to us at info@veedacr.com Partners in creating a healthier tomorrow. #Veeda #VeedaGroup #HealthDataSpecialists #Heads #Aquisition #CRO #ClinicalResearchOrganization

We are delighted to share comments from our Executive Vice Chairperson, Mr. Binoy Gardi, on Veeda's recent acquisition of Heads. Visit the link to know more about this acquisition https://bit.ly/4aeyQ0k or write to us at info@veedacr.com Partners in creating a healthier tomorrow. #Veeda #VeedaGroup #HealthDataSpecialists #Heads #Aquisition #CRO #ClinicalResearchOrganization

Join us as we embark on an exhilarating journey of innovation and excellence in delivering end-to-end drug development services on a global scale. We cordially invite you to watch and listen to our Group CEO, Dr. Mahesh Bhalgat, as he shares insightful comments on Veeda's recent acquisition of Health Data Specialists (Heads), a Europe-based CRO recognized as a global leader in Oncology Trials.   With Heads now part of the Veeda Group, we're well positioned to harness our collective strengths to advance drug development, foster equitable trial access, and accelerate the development of innovative medications that enhance patient care on a global scale. As we move forward, we're excited about the integration and the global reach that the acquisition brings.   To know more about this acquisition, write to us at info@veedacr.com or visit https://lnkd.in/dD2XS4cR BIONEEDS INDIA PRIVATE LIMITED   Partners in creating a healthier tomorrow. #Veeda #VeedaGroup #HealthDataSpecialists #Heads #Aquisition #CRO #ClinicalResearchOrganization #Bioneeds

We are delighted to announce that Veeda Clinical Research has acquired Health Data Specialists (Heads), a Europe-based Contract Research Organization (CRO), and a global leader in Oncology Trials, offering a complete range of clinical trial services from start-up to completion, from Phase I to IV. With this acquisition, Veeda’s global pharmaceutical and biotech clients can now leverage the unique and unparalleled suite of early to late-phase CRO services across Europe, US, and Asia Pacific. Here are some key benefits you can expect from this acquisition: - Integrated Service Portfolio: This acquisition signifies a pivotal moment, allowing us to seamlessly provide integrated services at all stages of drug development. BIONEEDS INDIA PRIVATE LIMITED, enhancing our preclinical capabilities, complements Veeda's early-phase services, while Heads strengthens our late-stage clinical trials capabilities - Putting Patients First: By integrating innovative approaches and expertise, we aim to improve patient comprehension, enhance patient recruitment, and encourage participation across diverse demographics, including individuals of varying racial and ethnic backgrounds, genders, ages, abilities, socioeconomic statuses, and educational levels - Global Reach: Our expanded global presence will enable efficient trial execution and access to multiple sites strategically located across 20+ different geographies worldwide. This will further strengthen our presence in Europe, North America and Asia Pacific region allowing us to offer localized support and insights, facilitating smoother collaboration - Access to KOL Network: With this acquisition, we are bringing together a talented team of scientists, researchers, and Key Opinion Leaders (KOLs) with an increased focus on Oncology Trials while gaining access to diverse patient populations worldwide   Together, as one unified team under the Veeda Group banner, we're committed to driving innovation & delivering excellence in your entire drug development journey. Click here to know more about this acquisition - https://bit.ly/3IRbkuc   To learn more, visit us at www.veedacr.com or write to us at info@veedacr.com Partners in creating a healthier tomorrow. #Veeda #VeedaGroup #HealthDataSpecialists #Heads #Aquisition #CRO #ClinicalResearchOrganization #Bioneeds

We are delighted to announce that Veeda Clinical Research has acquired Health Data Specialists (Heads), a Europe-based Contract Research Organization (CRO), and a global leader in Oncology Trials, offering a complete range of clinical trial services from start-up to completion, from Phase I to IV. With this acquisition, Veeda’s global pharmaceutical and biotech clients can now leverage the unique and unparalleled suite of early to late-phase CRO services across Europe, US, and Asia Pacific. Here are some key benefits you can expect from this acquisition: - Integrated Service Portfolio: This acquisition signifies a pivotal moment, allowing us to seamlessly provide integrated services at all stages of drug development. BIONEEDS INDIA PRIVATE LIMITED, enhancing our preclinical capabilities, complements Veeda's early-phase services, while Heads strengthens our late-stage clinical trials capabilities - Putting Patients First: By integrating innovative approaches and expertise, we aim to improve patient comprehension, enhance patient recruitment, and encourage participation across diverse demographics, including individuals of varying racial and ethnic backgrounds, genders, ages, abilities, socioeconomic statuses, and educational levels - Global Reach: Our expanded global presence will enable efficient trial execution and access to multiple sites strategically located across 20+ different geographies worldwide. This will further strengthen our presence in Europe, North America and Asia Pacific region allowing us to offer localized support and insights, facilitating smoother collaboration - Access to KOL Network: With this acquisition, we are bringing together a talented team of scientists, researchers, and Key Opinion Leaders (KOLs) with an increased focus on Oncology Trials while gaining access to diverse patient populations worldwide   Together, as one unified team under the Veeda Group banner, we're committed to driving innovation & delivering excellence in your entire drug development journey. Click here to know more about this acquisition - https://bit.ly/3IRbkuc   To learn more, visit us at www.veedacr.com or write to us at info@veedacr.com Partners in creating a healthier tomorrow. #Veeda #VeedaGroup #HealthDataSpecialists #Heads #Aquisition #CRO #ClinicalResearchOrganization #Bioneeds

Join us as we embark on an exhilarating journey of innovation and excellence in delivering end-to-end drug development services on a global scale. We cordially invite you to watch and listen to our Group CEO, Dr. Mahesh Bhalgat, as he shares insightful comments on Veeda's recent acquisition of Health Data Specialists (Heads), a Europe-based CRO recognized as a global leader in Oncology Trials.   With Heads now part of the Veeda Group, we're well positioned to harness our collective strengths to advance drug development, foster equitable trial access, and accelerate the development of innovative medications that enhance patient care on a global scale. As we move forward, we're excited about the integration and the global reach that the acquisition brings.   To know more about this acquisition, write to us at info@veedacr.com or visit https://lnkd.in/dD2XS4cR BIONEEDS INDIA PRIVATE LIMITED   Partners in creating a healthier tomorrow. #Veeda #VeedaGroup #HealthDataSpecialists #Heads #Aquisition #CRO #ClinicalResearchOrganization #Bioneeds